Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |